Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides
- PMID: 8254757
- PMCID: PMC236307
- DOI: 10.1128/JVI.68.1.463-468.1994
Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides
Abstract
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein has been shown to be extensively modified by N-linked glycosylation; however, the presence of O-linked carbohydrates on the glycoprotein has not been firmly established. We have found that enzymatic deglycosylation of the HIV-1 envelope glycoprotein with neuraminidase and O-glycosidase results in a decrease in the apparent molecular weight of the envelope glycoprotein. This result was observed in both vaccinia virus recombinant-derived envelope glycoproteins and glycoproteins derived from the IIIB, SG3, and HXB2, strains of HIV-1. The decrease in molecular weight was also observed when the envelope glycoprotein had been deglycosylated with N-glycanase F after treatment with neuraminidase and O-glycosidase, indicating that the decrease in apparent molecular weight was not attributable to the removal of N-linked carbohydrate. Treatment with neuraminidase, O-glycosidase, and N-glycanase F was found to be necessary to remove all radiolabel from [3H]glucosamine-labelled envelope glycoprotein, a result seen for both recombinant and HIV-1-derived envelope glycoprotein. [3H]glucosamine-labelled carbohydrates liberated by O-glycosidase treatment were separated by paper chromatography and were found to be of a size consistent with O-linked oligosaccharides. We, therefore, conclude that the HIV-1 envelope glycoprotein is modified by the addition of O-linked carbohydrates.
Similar articles
-
The E3-20.5K membrane protein of subgroup B human adenoviruses contains O-linked and complex N-linked oligosaccharides.Virology. 1995 Jul 10;210(2):335-44. doi: 10.1006/viro.1995.1350. Virology. 1995. PMID: 7618271
-
Complex-type N-linked oligosaccharides of gp120 from human immunodeficiency virus type 1 contain sulfated N-acetylglucosamine.J Virol. 1993 Feb;67(2):943-52. doi: 10.1128/JVI.67.2.943-952.1993. J Virol. 1993. PMID: 8419650 Free PMC article.
-
N-linked oligosaccharides of simian immunodeficiency virus envelope glycoproteins are dispensable for the interaction with the CD4 receptor.Biochem Biophys Res Commun. 1993 Jan 29;190(2):311-9. doi: 10.1006/bbrc.1993.1049. Biochem Biophys Res Commun. 1993. PMID: 8427576
-
N-glycosylation/deglycosylation as a mechanism for the post-translational modification/remodification of proteins.Glycoconj J. 1995 Jun;12(3):183-93. doi: 10.1007/BF00731318. Glycoconj J. 1995. PMID: 7496130 Review. No abstract available.
-
Expression, glycosylation, and modification of the spike (S) glycoprotein of SARS CoV.Methods Mol Biol. 2007;379:127-35. doi: 10.1007/978-1-59745-393-6_9. Methods Mol Biol. 2007. PMID: 17502675 Free PMC article. Review.
Cited by
-
Replication of HIV-1 envelope protein cytoplasmic domain variants in permissive and restrictive cells.Virology. 2019 Dec;538:1-10. doi: 10.1016/j.virol.2019.09.008. Epub 2019 Sep 18. Virology. 2019. PMID: 31550607 Free PMC article.
-
Infectivities of human and other primate lentiviruses are activated by desialylation of the virion surface.J Virol. 1996 Nov;70(11):7462-70. doi: 10.1128/JVI.70.11.7462-7470.1996. J Virol. 1996. PMID: 8892864 Free PMC article.
-
Antibody cross-competition analysis of the human immunodeficiency virus type 1 gp120 exterior envelope glycoprotein.J Virol. 1996 Mar;70(3):1863-72. doi: 10.1128/JVI.70.3.1863-1872.1996. J Virol. 1996. PMID: 8627711 Free PMC article.
-
Expression and characterization of a soluble form of tomato spotted wilt virus glycoprotein GN.J Virol. 2004 Dec;78(23):13197-206. doi: 10.1128/JVI.78.23.13197-13206.2004. J Virol. 2004. PMID: 15542672 Free PMC article.
-
V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.J Virol. 2000 Aug;74(15):6769-76. doi: 10.1128/jvi.74.15.6769-6776.2000. J Virol. 2000. PMID: 10888615 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources